These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8878590

  • 1. Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.
    Crémieux AC, Mghir AS, Bleton R, Manteau M, Belmatoug N, Massias L, Garry L, Sales N, Mazière B, Carbon C.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2111-6. PubMed ID: 8878590
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.
    Saleh Mghir A, Crémieux AC, Bleton R, Ismael F, Manteau M, Dautrey S, Massias L, Garry L, Sales N, Mazière B, Carbon C.
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2830-5. PubMed ID: 9797211
    [Abstract] [Full Text] [Related]

  • 3. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Cagni A, Chuard C, Vaudaux PE, Schrenzel J, Lew DP.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1655-60. PubMed ID: 7486895
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.
    Cochereau-Massin I, Bauchet J, Marrakchi-Benjaafar S, Saleh-Mghir A, Faurisson F, Vallois JM, Vallee E, Pocidalo JJ.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):633-6. PubMed ID: 8388193
    [Abstract] [Full Text] [Related]

  • 5. Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
    Marrakchi-Benjaafar S, Cochereau I, Pocidalo JJ, Carbon C.
    J Infect Dis; 1995 Nov; 172(5):1312-6. PubMed ID: 7594669
    [Abstract] [Full Text] [Related]

  • 6. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Maserati R, Cagni AE, Segú C.
    Chemotherapy; 1996 Nov; 42(2):133-9. PubMed ID: 8697888
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.
    Cremieux AC, Saleh-Mghir A, Vallois JM, Maziere B, Muffat-Joly M, Devine C, Bouvet A, Pocidalo JJ, Carbon C.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2216-21. PubMed ID: 1332590
    [Abstract] [Full Text] [Related]

  • 8. Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.
    Gatin L, Saleh-Mghir A, Tasse J, Ghout I, Laurent F, Crémieux AC.
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6496-500. PubMed ID: 25136014
    [Abstract] [Full Text] [Related]

  • 9. Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection.
    Ismael F, Bléton R, Saleh-Mghir A, Dautrey S, Massias L, Crémieux AC.
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3365-7. PubMed ID: 14506060
    [Abstract] [Full Text] [Related]

  • 10. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin.
    Kanellakopoulou K, Galanakis N, Giamarellos-Bourboulis EJ, Rifiotis C, Papakostas K, Andreopoulos A, Dounis E, Karagianakos P, Giamarellou H.
    J Antimicrob Chemother; 2000 Aug; 46(2):311-4. PubMed ID: 10933660
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    Vazquez J, Perri MB, Thal LA, Donabedian SA, Zervos MJ.
    J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
    [Abstract] [Full Text] [Related]

  • 16. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD, Zaniewski RP, Haskell SL, Kaczmarek FS, Maurice AE.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [Abstract] [Full Text] [Related]

  • 17. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C, Voss A, Milatovic D, Braveny I.
    Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
    Jones RN, Ballow CH, Schentag JJ, Johnson DM, Deinhart JA.
    Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
    [Abstract] [Full Text] [Related]

  • 20. Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa.
    Michéa-Hamzehpour M, Furet YX, Pechère JC.
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2091-7. PubMed ID: 1662023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.